COPD Research Study

Researchers at University of Miami Miller School of Medicine are conducting a study to investigate an inhaled steroid as a potential treatment for COPD.

Fast Facts

Ages 40-80

Diagnosed with COPD

Compensation Provided

Conducted in
Miami, FL

Study Background

Could adding an inhaled steroid to current COPD treatment improve pulmonary circulation?

Pulmonary vascular endothelial function measures how well blood moves between the heart and the lungs. When this system is not working properly, it could be an early sign of pulmonary hypertension, which is a serious complication of COPD.

Through this 3-month study, we want to know whether the addition of an inhaled steroid to current COPD treatment regimens improves pulmonary circulation function.

Study Background

Could adding an inhaled steroid to current COPD treatment improve pulmonary circulation?

Pulmonary vascular endothelial function measures how well blood moves between the heart and the lungs. When this system is not working properly, it could be an early sign of pulmonary hypertension, which is a serious complication of COPD.

Through this 3-month study, we want to know whether the addition of an inhaled steroid to current COPD treatment regimens improves pulmonary circulation function.

Additional Information

The purpose of this research study is to investigate whether the addition of an inhaled steroid to current COPD treatment regimens improves pulmonary circulation function.

You may qualify for a study if you meet the following criteria.

Inclusion Criteria:

  • Ages 40-80
  • Have been diagnosed with Chronic Obstructive Pulmonary Disease (COPD) by a physician
  • Not a current smoker
  • Do not use inhaled steroids as part of medication regimen
  • If female, not pregnant or breastfeeding
  • Regular use of a LAMA/LABA drug regimen for at least a month
  • No current respiratory infection
  • Do not currently use tobacco products (including smoking or vaping)
  • No regular use of pulmonary vasodilators
  • No physician diagnosis of obesity hypoventilation syndrome

This study will last 3 months and will involve 5 study assessments. Each study visit will last approximately 2-3 hours and will consist of non-invasive measurements such as breathing tests and echocardiography. 

As a participant, you can earn up to $750 for completing all study activities. 

There is no cost for you to participate in our research study.